IL128280A0 - Method fro treating bipolar disorder - Google Patents

Method fro treating bipolar disorder

Info

Publication number
IL128280A0
IL128280A0 IL12828097A IL12828097A IL128280A0 IL 128280 A0 IL128280 A0 IL 128280A0 IL 12828097 A IL12828097 A IL 12828097A IL 12828097 A IL12828097 A IL 12828097A IL 128280 A0 IL128280 A0 IL 128280A0
Authority
IL
Israel
Prior art keywords
bipolar disorder
treating bipolar
method fro
fro treating
disorder
Prior art date
Application number
IL12828097A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL128280A0 publication Critical patent/IL128280A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Processing Of Solid Wastes (AREA)
  • Press Drives And Press Lines (AREA)
IL12828097A 1996-08-01 1997-07-28 Method fro treating bipolar disorder IL128280A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2290096P 1996-08-01 1996-08-01
PCT/US1997/013185 WO1998005324A1 (fr) 1996-08-01 1997-07-28 Procede de traitement des maladies affectives bipolaires

Publications (1)

Publication Number Publication Date
IL128280A0 true IL128280A0 (en) 1999-11-30

Family

ID=21812011

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12828097A IL128280A0 (en) 1996-08-01 1997-07-28 Method fro treating bipolar disorder

Country Status (19)

Country Link
EP (1) EP0821955B1 (fr)
JP (1) JP2000515547A (fr)
KR (1) KR20000029647A (fr)
CN (1) CN1226165A (fr)
AT (1) ATE213413T1 (fr)
AU (1) AU716972B2 (fr)
BR (1) BR9710901A (fr)
CA (1) CA2261802C (fr)
CZ (1) CZ27299A3 (fr)
DE (1) DE69710526T2 (fr)
DK (1) DK0821955T3 (fr)
EA (1) EA199900174A1 (fr)
ES (1) ES2171838T3 (fr)
HU (1) HUP9904578A2 (fr)
IL (1) IL128280A0 (fr)
NO (1) NO990436D0 (fr)
PL (1) PL331407A1 (fr)
PT (1) PT821955E (fr)
WO (1) WO1998005324A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3061821T (pt) 2009-07-22 2019-09-05 PureTech Health LLC Composições para tratamento de distúrbios melhorados por ativação de recetores muscarínicos
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
KR102408292B1 (ko) 2018-09-28 2022-06-10 카루나 세러퓨틱스 인코포레이티드 무스카린성 수용체 활성화에 의해 개선된 장애의 치료를 위한 조성물 및 방법
CN111430027B (zh) * 2020-03-18 2023-04-28 浙江大学 基于肠道微生物的双相情感障碍生物标志物及其筛选应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
KR100360575B1 (ko) * 1993-08-19 2003-03-10 노보 노르디스크 에이/에스 정신분열증및정신분열형질환치료용약제학적조성물
US5646289A (en) * 1994-10-24 1997-07-08 Eli Lilly And Company Heterocyclic compounds and their preparation and use
AU4139096A (en) * 1994-10-31 1996-05-23 Eli Lilly And Company Method for treating anxiety
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety

Also Published As

Publication number Publication date
EP0821955A3 (fr) 1998-04-22
EP0821955A2 (fr) 1998-02-04
AU4046897A (en) 1998-02-25
CA2261802C (fr) 2006-11-07
JP2000515547A (ja) 2000-11-21
HUP9904578A2 (hu) 2000-06-28
AU716972B2 (en) 2000-03-09
DE69710526D1 (de) 2002-03-28
PL331407A1 (en) 1999-07-19
CN1226165A (zh) 1999-08-18
ES2171838T3 (es) 2002-09-16
CA2261802A1 (fr) 1998-02-12
DK0821955T3 (da) 2002-03-18
PT821955E (pt) 2002-07-31
NO990436L (no) 1999-01-29
KR20000029647A (ko) 2000-05-25
DE69710526T2 (de) 2002-10-02
ATE213413T1 (de) 2002-03-15
BR9710901A (pt) 1999-08-17
EA199900174A1 (ru) 1999-08-26
CZ27299A3 (cs) 1999-08-11
WO1998005324A1 (fr) 1998-02-12
EP0821955B1 (fr) 2002-02-20
NO990436D0 (no) 1999-01-29

Similar Documents

Publication Publication Date Title
SG47520A1 (en) New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
TW269678B (fr)
MX9302932A (es) Nuevas 4-aza-5&-androstan-3-onas 7b-substituidas como inhibidores de la5&-reductasa.
HU9301362D0 (en) Method for producing 4-aryl-piperazines and 4-aryl-piperidines
IL119118A0 (en) 9-Ú(Haloacyl) amido¾-7- (substituted)-6- demethyl-6-deoxytetracycline intermediates
GB9722520D0 (en) Compounds
CY2543B1 (en) 9-Ä(Substituted glycyl)amidoÜ-6-(substituted)-5-hydroxy-6-deoxytetracyclines
GB9406857D0 (en) Improvements in or relating to organic compounds
HU9403311D0 (en) NEW 7BéTA-SUBSTITUTED-4-AZA-5ALPHA-CHOLESTAN-ONES AS 5-ALPHA-REDUCTASE INHIBITORS
DE69814635D1 (de) Verfahren zur herstellung von 2-hydroxybenzamidderivaten
EP0924199A4 (fr)
TW287103B (fr)
IL147575A0 (en) Method for purifying keratinocyte growth factors
PL286043A1 (en) Method for manufacturing new proteins
IL128280A0 (en) Method fro treating bipolar disorder
ZA976854B (en) Treatment of psychotic disorders.
HUT70757A (en) Pharmaceutical compositions for treating skin disorders
PL335186A1 (en) Method of treating an iron salts containing solution
MY133014A (en) Method for treating copd
ZA958609B (en) Method for purifying keratinocyte growth factors
IL112469A0 (en) Composition for the treatment of an epidermal disorder
ZA983298B (en) Methods for reducing fibrinogen.
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
ES2157952T3 (es) Preparacion de derivados de beta-lactama e intermediarios.
GR3036968T3 (en) Adamantyl substituted oxindoles as pharmaceutical agents